MULTICENTER PHASE II STUDY OF PACLITAXEL, CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN CHEMOTHERAPY-NAIVE PATIENTS WITH RELAPSED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCC-HN)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles